Global Keratoconus Treatment Market 2028

Global Keratoconus Treatment Market 2028

$4450 – $6250

According to CRI, the global keratoconus treatment market is expected to exhibit a healthy CAGR of 4.72% during the review period.

SKU: MRFR210191 Category: Tags: , , , , ,

Description

Global Keratoconus Treatment Market

Market Overview
According to CRI, the global keratoconus treatment market is expected to exhibit a healthy CAGR of 4.72% during the review period. Keratoconus is a reformist eye condition where the cornea, normally round and little, seems cone-like. Keratoconus often has to do with light overexposure, steady eye scouring, inappropriately fitting contact focal points and persistent eye aggravation. Keratoconus care relies upon the reality of the illness and how effectively the condition advances.

The market growth of the global keratoconus treatment market is driven by the rising incidence and prevalence of keratoconus disorders, Increasing ultraviolet and sun exposure, and supportive government regulations. additionally, increasing healthcare infrastructure in developing countries further provides significant growth opportunities for the market. However, the Side-effects of keratoconus treatment are estimated to restrain the growth of the global market during the review period.

Segment Overview
The Global Keratoconus Treatment Market has been classified into Keratoconus Type, Treatment Type.
Based on Keratoconus Type the global market is classified into Corneal Hydrops, Forme Fruste Keratoconus Posterior Keratoconus, Keratoglobus, Pellucid Marginal Degeneration, and Others.

Depending on Treatment Type the market has been divided into Corneal Cross-Linking, Lenses, Surgery, and others. The lenses segment is further classified into Soft Contact Lenses, Gas Permeable Contact Lenses, Scleral, and Semi-Scleral Lenses Piggybacking Contact Lenses, Hybrid Contact Lenses, Prosthetic Lenses, and Others. The Surgery is subcategorized into Corneal Transplant, Intacs, and Others. The End User segment classifies the global market into Eye Clinics, Hospitals, and Others.

Regional Analysis:
Geographically, the global Keratoconus Treatment market has been studied across the Americas, Europe, Asia-Pacific, and Middle East & Africa.
The Americas is set to lead the global market owing to the well-established healthcare industry and medical facilities and accelerating technological innovations in the region. Europe contributed a significant share of the global keratoconus treatment market owing to the rising support from the government, the advanced medical industry in the region, and the increasing cases of keratoconus.

Asia-Pacific is likely to register the fastest-growing regional market owing to the high merger and acquisition activities and product approvals in the region. The keratoconus treatment market in the Middle East and Africa is relied upon to observe consistent development during the survey time frame. In the Middle East, the reception pace of more current analytic instruments was high in South Africa, the UAE, and Saudi Arabia. With the expanding vital drives by private and public firms and associations, the development rate is relied upon to ascend in the following not many years.

Major Players

The major market players of global keratoconus treatment include HOYA Vision Care Company (Japan), Menicon Co., Ltd. (Japan), Cooper Companies, Inc. (US), Bausch Health (Canada), SynergEyes (US), Carl Zeiss Meditec AG (Germany), Contamac (UK), SEED Co., Ltd (Japan), Novartis AG (Switzerland), and Johnson & Johnson Services, Inc. (US).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

 

Global Stretch Marks Treatment Market Analysis and Forecast Report 2030

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 14 1.1 OVERVIEW 14 2 MARKET INTRODUCTION 15 2.1 SCOPE OF THE STUDY 15 2.2 RESEARCH OBJECTIVE 15 2.3 LIST OF ASSUMPTIONS 16 3 RESEARCH METHODOLOGY 17 3.1 OVERVIEW 17 3.2 DATA MINING 17 3.3 SECONDARY RESEARCH 18 3.4 PRIMARY RESEARCH 19 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 20 3.5 FORECASTING TECHNIQUES 21 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22 3.6.1 BOTTOM-UP APPROACH 22 3.6.2 TOP-DOWN APPROACH 23 3.7 DATA TRIANGULATION 24 3.8 VALIDATION 24 4 MARKET DYNAMICS 25 4.1 INTRODUCTION 25 4.2 DRIVERS 26 4.2.1 INCREASING INCIDENCE AND PREVALENCE OF THE KERATOCONUS DISORDER 26 4.2.2 INCREASING ULTRAVIOLET AND SUN EXPOSURE 26 4.2.3 FAVORABLE GOVERNMENT FUNDING 27 4.3 RESTRAINTS 28 4.3.1 LACK OF AWARENESS 28 4.3.2 SIDE-EFFECTS OF KERATOCONUS TREATMENT 28 4.4 OPPORTUNITIES 29 4.4.1 EMERGING MARKETS OF KERATOCONUS TREATMENT 29 5 MARKET FACTOR ANALYSIS 30 5.1 VALUE CHAIN ANALYSIS 30 5.1.1 R&D AND DESIGNING 31 5.1.2 MANUFACTURING 31 5.1.3 DISTRIBUTION 31 5.1.4 MARKETING & SALES 31 5.2 PORTER’S FIVE FORCES MODEL 31 5.2.1 THREAT OF NEW ENTRANTS 32 5.2.2 BARGAINING POWER OF SUPPLIERS 32 5.2.3 THREAT OF SUBSTITUTES 33 5.2.4 BARGAINING POWER OF BUYERS 33 5.2.5 INTENSITY OF RIVALRY 33 5.3 COVID-19 IMPACT ANALYSIS 33 5.3.1 IMPACT ON MARKET GROWTH 33 5.3.2 IMPACT ON DEMAND AND SUPPLY 34 5.3.3 IMPACT ON MAJOR PLAYERS 34 6 GLOBAL KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TYPE 35 6.1 OVERVIEW 35 6.2 CORNEAL HYDROPS 36 6.3 FORME FRUSTE KERATOCONUS 36 6.4 POSTERIOR KERATOCONUS 37 6.5 KERATOGLOBUS 37 6.6 PELLUCID MARGINAL DEGENERATION 38 6.7 OTHERS 38 7 GLOBAL KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE 39 7.1 OVERVIEW 39 7.2 CORNEAL CROSS-LINKING 40 7.3 LENSES 40 7.4 SURGERY 42 7.5 OTHERS 43 8 GLOBAL KERATOCONUS TREATMENT MARKET, BY END USER 44 8.1 OVERVIEW 44 8.2 EYE CLINICS 45 8.3 HOSPITALS 45 8.4 OTHERS 46 9 GLOBAL KERATOCONUS TREATMENT MARKET, BY REGION 47 9.1 OVERVIEW 47 9.2 AMERICA 48 9.2.1 NORTH AMERICA 52 9.2.1.1 US 55 9.2.1.2 CANADA 57 9.2.2 LATIN AMERICA 59 9.3 EUROPE 61 9.3.1 WESTERN EUROPE 64 9.3.1.1 GERMANY 67 9.3.1.2 FRANCE 69 9.3.1.3 UK 71 9.3.1.4 ITALY 73 9.3.1.5 SPAIN 75 9.3.1.6 REST OF WESTERN EUROPE 77 9.3.2 EASTERN EUROPE 79 9.4 ASIA-PACIFIC 81 9.4.1 CHINA 84 9.4.2 INDIA 86 9.4.3 JAPAN 88 9.4.4 SOUTH KOREA 90 9.4.5 AUSTRALIA 92 9.4.6 REST OF ASIA-PACIFIC 94 9.5 MIDDLE EAST & AFRICA 96 9.5.1 MIDDLE EAST 99 9.5.2 AFRICA 101 10 COMPETITIVE LANDSCAPE 103 10.1 OVERVIEW 103 10.2 COMPETITIVE BENCHMARKING 104 10.3 GLOBAL KERATOCONUS TREATMENT MARKET: COMPANY RANKING, 2019 105 10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL KERATOCONUS TREATMENT MARKET 106 10.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 106 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 107 10.6.1 PRODUCT APPROVALS AND LAUNCHES 107 10.6.2 ACQUISITIONS & SPIN OFF 108 10.7 FINANCIAL MATRIX 109 11 COMPANY PROFILES 110 11.1 BAUSCH HEALTH COMPANIES INC. 110 11.1.1 COMPANY OVERVIEW 110 11.1.2 FINANCIAL OVERVIEW 111 11.1.3 PRODUCTS/SERVICES OFFERED 112 11.1.4 KEY DEVELOPMENTS 112 11.1.5 SWOT ANALYSIS 113 11.1.6 KEY STRATEGIES 113 11.2 NOVARTIS AG 114 11.2.1 COMPANY OVERVIEW 114 11.2.2 FINANCIAL OVERVIEW 115 11.2.3 PRODUCTS/SERVICES OFFERED 115 11.2.4 KEY DEVELOPMENTS 116 11.2.5 SWOT ANALYSIS 116 11.2.6 KEY STRATEGIES 116 11.3 THE COOPER COMPANIES, INC. 117 11.3.1 COMPANY OVERVIEW 117 11.3.2 FINANCIAL OVERVIEW 117 11.3.3 PRODUCTS/SERVICES OFFERED 118 11.3.4 KEY DEVELOPMENTS 118 11.3.5 SWOT ANALYSIS 119 11.3.6 KEY STRATEGIES 119 11.4 HOYA CORPORATION 120 11.4.1 COMPANY OVERVIEW 120 11.4.2 FINANCIAL OVERVIEW 120 11.4.3 PRODUCTS/SERVICES OFFERED 121 11.4.4 KEY DEVELOPMENTS 121 11.4.5 SWOT ANALYSIS 122 11.4.6 KEY STRATEGIES 122 11.5 JOHNSON & JOHNSON SERVICES, INC. 123 11.5.1 COMPANY OVERVIEW 123 11.5.2 FINANCIAL OVERVIEW 124 11.5.3 PRODUCTS/SERVICES OFFERED 125 11.5.4 KEY DEVELOPMENTS 126 11.5.5 SWOT ANALYSIS 126 11.5.6 KEY STRATEGIES 126 11.6 CARL ZEISS MEDITEC AG 127 11.6.1 COMPANY OVERVIEW 127 11.6.2 FINANCIAL OVERVIEW 127 11.6.3 RODUCTS/SERVICES OFFERED 128 11.6.4 KEY DEVELOPMENTS 128 11.6.5 SWOT ANALYSIS 129 11.6.6 KEY STRATEGIES 129 11.7 CONTAMAC 130 11.7.1 COMPANY OVERVIEW 130 11.7.2 FINANCIAL OVERVIEW 130 11.7.3 PRODUCTS/SERVICES OFFERED 130 11.7.4 KEY DEVELOPMENTS 131 11.7.5 SWOT ANALYSIS 131 11.7.6 KEY STRATEGIES 131 11.8 SEED CO., LTD 132 11.8.1 COMPANY OVERVIEW 132 11.8.2 FINANCIAL OVERVIEW 132 11.8.3 PRODUCTS/SERVICES OFFERED 133 11.8.4 KEY DEVELOPMENTS 133 11.8.5 SWOT ANALYSIS 134 11.8.6 KEY STRATEGIES 134 11.9 SYNERGEYES 135 11.9.1 COMPANY OVERVIEW 135 11.9.2 FINANCIAL OVERVIEW 135 11.9.3 PRODUCTS/SERVICES OFFERED 135 11.9.4 KEY DEVELOPMENTS 136 11.9.5 SWOT ANALYSIS 136 11.9.6 KEY STRATEGIES 136 11.10 MENICON CO., LTD 137 11.10.1 COMPANY OVERVIEW 137 11.10.2 FINANCIAL OVERVIEW 137 11.10.3 PRODUCTS/SERVICES OFFERED 138 11.10.4 KEY DEVELOPMENTS 139 11.10.5 SWOT ANALYSIS 139 11.10.6 KEY STRATEGIES 139 12 APPENDIX 140 12.1 REFERENCES 140 12.2 RELATED REPORTS 140

Reviews

There are no reviews yet.

Be the first to review “Global Keratoconus Treatment Market 2028”

Related products